Literature DB >> 28431009

Artefact-free late gadolinium enhancement imaging in patients with implanted cardiac devices using a modified broadband sequence: current strategies and results from a real-world patient cohort.

Sebastian Hilbert1, Alexander Weber1, Kay Nehrke2, Peter Börnert2, Bernhard Schnackenburg2, Sabrina Oebel1, Ricardo Spampinato3, Cathleen Rogge1, Sergio Richter1, Gerhard Hindricks1, Ingo Paetsch1, Cosima Jahnke1.   

Abstract

Aims: Cardiac magnetic resonance (CMR) imaging in patients with implanted cardiac devices is often limited by device-related imaging artefacts. Limitations can potentially be overcome by employing a broadband late gadolinium enhancement (LGE)-CMR imaging technique. The purpose of this study was to investigate the relationship between implanted cardiac devices and the optimal frequency offset on broadband LGE-CMR imaging to increase the artefact-free visibility of myocardial segments. Methods and results: A phantom study was performed to characterize magnetic field disturbances related to 15 different cardiac devices. This was complemented by B0 and B1+ imaging of three different device types in four healthy volunteers. Findings were validated in 28 patients with an indication for arrhythmogenic substrate characterization before catheter ablation. In the phantom study, the placement of a PM, implantable cardioverter-defibrillator (ICD) or CRT-D generator led to a significant impairment of the radiofrequency field. B0 mapping in phantom and volunteers showed the highest off-resonance maximum with CRT-D systems with the maximum off-resonance significantly decreasing for ICD or PM systems, respectively. In all patients, with conventional LGE imaging 73.1% (61.5-92.3%) of LV segments were free of device-related artefacts, while with the broadband LGE technique, a significant increase of artefact-free segments was achieved [96.4% (85.7-100%); P = 0.00008].
Conclusion: Using a modified broadband sequence for LGE imaging significantly increased the number of artefact-free myocardial segments thereby leading to improved diagnostic value of the CMR exam. Since the occurrence and extent of hyperintensity artefacts are closely related to the individual device, more studies are warranted to evaluate if the results can be extrapolated to other devices and manufacturers.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28431009     DOI: 10.1093/europace/eux016

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  12 in total

Review 1.  [Cardiovascular magnetic resonance imaging in patients with cardiac devices : Useful tool or just artifacts?]

Authors:  Sebastian Hilbert; Gerhard Hindricks
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2022-07-04

Review 2.  Role of Cardiac MRI Imaging of Focal and Diffuse Inflammation and Fibrosis in Cardiomyopathy Patients Who Have Pacemakers/ICD Devices.

Authors:  Ananna Zaman; Samantha Zhao; Jordana Kron; Antonio Abbate; Anna Tomdio; W Gregory Hundley; Jennifer H Jordan
Journal:  Curr Cardiol Rep       Date:  2022-08-19       Impact factor: 3.955

3.  Reducing cardiac implantable electronic device-induced artefacts in cardiac magnetic resonance imaging.

Authors:  Aino-Maija Vuorinen; Lauri Lehmonen; Jarkko Karvonen; Miia Holmström; Sari Kivistö; Touko Kaasalainen
Journal:  Eur Radiol       Date:  2022-08-27       Impact factor: 7.034

4.  Cardiac magnetic resonance imaging using wideband sequences in patients with nonconditional cardiac implanted electronic devices.

Authors:  Duc H Do; Vaughn Eyvazian; Aileen J Bayoneta; Peng Hu; J Paul Finn; Jason S Bradfield; Kalyanam Shivkumar; Noel G Boyle
Journal:  Heart Rhythm       Date:  2017-10-07       Impact factor: 6.343

Review 5.  [Benefits of cardiac magnetic resonance diagnostics in patients with heart rhythm disorders : From risk stratification to interventional procedures].

Authors:  S Oebel; C Jahnke; G Hindricks; I Paetsch
Journal:  Herz       Date:  2022-03-11       Impact factor: 1.443

6.  Clinical utility of cardiovascular magnetic resonance imaging in patients with implantable cardioverter defibrillators presenting with electrical instability or worsening heart failure symptoms.

Authors:  Frank Lindemann; Sabrina Oebel; Ingo Paetsch; Arash Arya; Nikolaos Dagres; Sergio Richter; Borislav Dinov; Sebastian Hilbert; Susanne Loebe; Clara Stegmann; Michael Doering; Andreas Bollmann; Gerhard Hindricks; Cosima Jahnke
Journal:  J Cardiovasc Magn Reson       Date:  2020-05-11       Impact factor: 5.364

7.  Evaluation of image quality of wideband single-shot late gadolinium-enhancement MRI in patients with a cardiac implantable electronic device.

Authors:  Sarah M Schwartz; Ashitha Pathrose; Ali M Serhal; Ann B Ragin; Jessica Charron; Bradley P Knight; Rod S Passman; Ryan J Avery; Daniel Kim
Journal:  J Cardiovasc Electrophysiol       Date:  2020-11-13

8.  Factors predictive for delayed enhancement in cardiac resonance imaging in patients undergoing catheter ablation of premature ventricular complexes.

Authors:  Michael Ghannam; Konstantinos C Siontis; Hyungjin Myra Kim; Hubert Cochet; Pierre Jais; Mehdi Juhoor Eng; Anil Attili; Ghaith Sharaf-Dabbagh; Rakesh Latchamsetty; Krit Jongnarangsin; Fred Morady; Frank Bogun
Journal:  Heart Rhythm O2       Date:  2020-11-12

9.  Clinical experience regarding safety and diagnostic value of cardiovascular magnetic resonance in patients with a subcutaneous implanted cardioverter/defibrillator (S-ICD) at 1.5 T.

Authors:  Viktoria Holtstiege; Claudia Meier; Michael Bietenbeck; Grigorios Chatzantonis; Anca Florian; Julia Köbe; Florian Reinke; Lars Eckardt; Ali Yilmaz
Journal:  J Cardiovasc Magn Reson       Date:  2020-05-18       Impact factor: 5.364

Review 10.  Magnetic resonance imaging guidance for the optimization of ventricular tachycardia ablation.

Authors:  Rahul K Mukherjee; John Whitaker; Steven E Williams; Reza Razavi; Mark D O'Neill
Journal:  Europace       Date:  2018-11-01       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.